SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-080594
Filing Date
2021-03-15
Accepted
2021-03-15 08:30:52
Documents
3
Period of Report
2021-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d286718d8k.htm 8-K 19538
2 EX-99.1 d286718dex991.htm EX-99.1 8274
3 GRAPHIC g286718g15s81.jpg GRAPHIC 6572
  Complete submission text file 0001193125-21-080594.txt   38222
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39386 | Film No.: 21739926
SIC: 2834 Pharmaceutical Preparations